| For: |
Zhang YL, Zhang YC, Han W, Li YM, Wang GN, Yuan S, Wei FX, Wang JF, Jiang JJ, Zhang YW. Effect of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11287.htm |
| Number | Citing Articles |
| 1 |
Yiming Liu, Xiaodi Zhang, Ting Sun, Junchang Jiang, Ying Li, Mingliang Chen, Zhen Wei, Weiqin Jiang, Linfu Zhou. Knockdown of Golgi phosphoprotein 2 inhibits hepatocellular carcinoma cell proliferation and motility. Oncotarget 2016; 7(16) doi: 10.18632/oncotarget.7271
|
| 2 |
Rong Yang, Li Qian. Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression. Integrative Cancer Therapies 2022; 21 doi: 10.1177/15347354221114100
|
| 3 |
Yazhen Zhang, Aifang Xu, Yujiao Jin, Jing Gao, Jiahui He. Diagnostic value of serum Golgi protein 73 in liver fibrosis and inflammation in patients with autoimmune hepatitis. Medicine 2025; 104(26) doi: 10.1097/MD.0000000000043064
|
| 4 |
Anirban Kumar Maity, Ajay Mallick, Debbie C. Crans, Srikanta Goswami, Soumyajit Roy. Molecular hydrogen in cancer: reprogramming oncogenic signaling pathways and emerging pharmacological potential. Frontiers in Chemical Biology 2026; 5 doi: 10.3389/fchbi.2026.1915345
|
| 5 |
Jingjing Tong, Mingjie Yao, Xiuying Mu, Leijie Wang, Xiajie Wen, Xingran Zhai, Xiang Xu, Yu Wang, Jing Chen, Xiangwei Zhai, Chongdan Guan, Fengmin Lu, Jinhua Hu. Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF. Journal of Clinical and Translational Hepatology 2022; 10(3) doi: 10.14218/JCTH.2020.00133
|
| 6 |
Ying Yang, Qiang Liu, Hua Zhang, Huarong Zhao, Ruin Mao, Zhipeng Li, Sha Ya, Chunli Jia, Yongxing Bao. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma. Oncology Reports 2017; 37(2) doi: 10.3892/or.2017.5351
|
| 7 |
Mingdong Lu, Wenqin Jiang, Zhekai Liu, Yiqing Liu, Fangli Wu, Weibo Jin. Development of a Dual Gene-Targeted Multi-Sirna with Branched Structure and Its Role in the Therapy of Liver Cancer. Pharmaceuticals 2025; 18(12) doi: 10.3390/ph18121844
|
| 8 |
Mingjie Yao, Leijie Wang, Patrick S. C. Leung, Yanmei Li, Shuhong Liu, Lu Wang, Xiaodong Guo, Guangde Zhou, Ying Yan, Guiwen Guan, Xiangmei Chen, Christopher L. Bowlus, Tianhui Liu, Jidong Jia, M. Eric Gershwin, Xiong Ma, Jingmin Zhao, Fengmin Lu. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clinical Reviews in Allergy & Immunology 2018; 54(2) doi: 10.1007/s12016-017-8655-y
|
| 9 |
Yanan Wang, Yu-Jui Yvonne Wan. Golgi protein 73, hepatocellular carcinoma and other types of cancers. Liver Research 2020; 4(4) doi: 10.1016/j.livres.2020.09.003
|
| 10 |
Yanyan Xia, Yuanying Zhang, Mengjiao Shen, Hongpan Xu, Zhiyang Li, Nongyue He. Golgi protein 73 and its diagnostic value in liver diseases. Cell Proliferation 2019; 52(2) doi: 10.1111/cpr.12538
|
| 11 |
Jiuliang Yan, Binghai Zhou, Hui Li, Lei Guo, Qinghai Ye. Recent advances of GOLM1 in hepatocellular carcinoma. Hepatic Oncology 2020; 7(2) doi: 10.2217/hep-2020-0006
|
| 12 |
Nikolaos K Gatselis, Tamás Tornai, Zakera Shums, Kalliopi Zachou, Asterios Saitis, Stella Gabeta, Roger Albesa, Gary L Norman, Mária Papp, George N Dalekos. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients. World Journal of Gastroenterology 2020; 26(34): 5130-5145 doi: 10.3748/wjg.v26.i34.5130
|